Ambroxol, solution for injections/infusions 7.5 mg/ml, 2 ml each;Clozapine, tablets, 100 mg each;Metamizole sodium, solution for injection, 500 mg/ml, 2 ml;Chloropyramine, solution for injection, 20 mg/ml, 1 ml each;Aripiprazole, tablets, 15 mg each;;Valproic acid, tablets, 300 mg each;Venlafaxine, capsules/tablets, 75 mg each;Activated charcoal tablets/capsules of 250 mg each;Glucose solution for infusions 5% in 200 ml;Diclofenac solution for injection 25 mg/ml;Ondansetron solution for injectio
By: Gurenko Kostyantyn Valeriyovych📍 UkraineClosed
Key Information
| Reference | GB-UA-2026-11-06-013107-a |
|---|
| Deadline | Nov 11, 2026 12:00 AM |
|---|
| Estimated Value | UAH 190,074,775.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 79021, Ukraine, Lviv Region, Lviv, KULPARKIVSKA Street, Building 95 |
|---|
| Published | Nov 6, 2026 |
|---|
Description
Ambroxol, solution for injections/infusions 7.5 mg/ml, 2 ml each;Clozapine, tablets, 100 mg each;Metamizole sodium, solution for injection, 500 mg/ml, 2 ml;Chloropyramine, solution for injection, 20 m...
Full details are available after unlocking this tender.